Cell Signalling and Targeted therapy

Our group studies the regulation of cellular signalling and how dysregulation of intracellular signaling pathways may contribute to development of diseases such as cancer. We are particularly interested in understanding how specific protein kinases and protein phosphatases contributes to these processes. Our ultimate goal is to use this knowledge to identify novel strategies for pharmacological treatment of cancer.